About Us

About BioIP Capital

BIOIP CAPITAL PTE. LTD. is a Singapore-based multidisciplinary platform operating at the intersection of biotechnology, medical research, scientific innovation, real-world assets, and emerging digital infrastructure. We were established with a clear vision: to bridge deep science with modern capital structures and operational execution, enabling innovation to move from research to real-world impact.

With SGD 52 million under management, a growing portfolio of ventures and assets, and 12 strategic partnerships including venture funds, laboratories, and platform sponsors, BioIP Capital positions itself as a builder, operator, and strategic partner across complex innovation ecosystems.

Our Vision

We believe the future of science, healthcare, and sustainable assets requires new models of collaboration, funding, and ownership. Traditional boundaries between research, capital, infrastructure, and technology are dissolving. BioIP Capital exists to navigate and integrate these domains responsibly.

Our vision is to enable tomorrow’s breakthroughs today — supporting scientific discovery, translational medicine, and asset innovation through disciplined governance, strategic capital deployment, and forward-looking infrastructure.

Who We Are

BioIP Capital is not a single-purpose entity. We operate as an integrated platform combining

Scientific and medical research alignment
Venture and structured capital solutions
Real-world asset development and transformation
Tokenization and blockchain-enabled infrastructure
Sponsor and pre-IPO coordination services

Our activities span biotech, immunotherapy, diagnostics, botanical and traditional science, as well as real estate, laboratories, hospitality infrastructure, mining operations, and digital asset frameworks that support transparency and long-term value creation.

Scientific & Research Foundations

At our core, BioIP Capital is science-driven. We work closely with research laboratories, academic institutions, and scientific advisors to support innovation grounded in evidence, reproducibility, and regulatory awareness.

Our areas of focus include:

Medical and biomedical research
Immunotherapy and translational science
Botanical and traditional science research
Laboratory development and research infrastructure

By supporting both research programs and the physical environments in which science happens, we ensure innovation is not constrained by operational or structural limitations.

Capital, Structures & Smart Money

BioIP Capital deploys capital through flexible, fit-for-purpose structures designed to align stakeholders while preserving governance and long-term vision.

We operate across:

Venture capital participation and co-investments
Special Purpose Vehicles (SPVs)
SAFE and convertible loan / note structures
Venture joint partnerships
Equity crowdfunding initiatives

This approach allows us to support projects at different stages — from early research and infrastructure build-out to growth, restructuring, and pre-IPO readiness.

Partnerships & Ecosystem

We operate within a broad ecosystem of venture funds, research institutions, laboratories, platform providers, legal advisors, and infrastructure partners.

Our 12+ partnerships include VC funds, labs, sponsors, and service providers, enabling us to deliver integrated solutions rather than fragmented services.

Prominent individuals and institutions trust our approach, governance discipline, and long-term vision. Partner identities are disclosed where appropriate and with consent.

Real-World Assets & Infrastructure

Beyond intellectual capital, BioIP Capital actively engages in real-world assets (RWA) that support innovation ecosystems.

Our activities include:

Acquisition, development, and divestment of lab-ready buildings

Transformation of hospitality and real estate assets into research-supporting infrastructure

Strategic involvement in mining operations linked to materials relevant to scientific and industrial supply chains

These assets are not treated as isolated investments, but as functional components of a broader innovation platform.

Tokenization & Digital Infrastructure

BioIP Capital embraces blockchain technology as an enabling layer, not a speculative tool. We explore and implement tokenization of real-world assets, botanical research outputs, and structured interests where appropriate and compliant.

Our work in this area focuses on:

Transparency and traceability
Responsible tokenization frameworks
Smart contract governance and audit alignment
Integration with traditional legal and operational structures

Blockchain is used to enhance accountability, access, and operational efficiency, always within clearly defined governance and compliance frameworks.

Sponsor & Pre-IPO Management

BioIP Capital supports companies and asset platforms on the path toward institutional readiness and public market engagement.

Our sponsor and pre-IPO services include:

Strategic coordination with sponsors and advisors
Investor communications and positioning
Structural preparation for listings and market entry
Management of investor programs prior to liquidity events

We act as a long-term partner, aligning operational readiness with market expectations.

Governance, Ethics & Responsibility

BioIP Capital is committed to:

Ethical research alignment
Strong governance and transparency
Protection of intellectual property
Prevention of misrepresentation and impersonation
Responsible innovation and capital deployment

All activities are conducted with respect for applicable laws, standards, and best practices across jurisdictions.

Our Philosophy

We believe:

Science deserves patient, intelligent capital

Assets should serve ecosystems, not extract from them

Technology should enable trust, not replace responsibility

Long-term value is built through discipline, not shortcuts

BioIP Capital is built for builders, researchers, partners, and institutions who share this philosophy.

Looking Forward

As science, capital, and infrastructure continue to converge, BioIP Capital will remain focused on exploration, execution, and responsible growth. We are committed to shaping ecosystems that endure — from laboratories and research platforms to digital frameworks and real-world assets.

We explore tomorrow’s world — responsibly, rigorously, and with purpose.